Live Event in Baltimore: The 17th Annual Johns Hopkins Multiple Sclerosis Symposium Workshop
Event Date
Saturday, December 13, 2025
Location
Sheraton Baltimore North Hotel
903 Dulaney Valley Rd, Towson, MD 21204
Event Time
7:30am - 12:30pm, EST
Completion Time
4 Hours
Specialty
Education, Hospitalist, Neurology, Primary Care
Topic(s)
Multiple Sclerosis, Parkinson's & Movement Disorders
Credit Available
- Physicians — maximum of 4.0 AMA PRA Category 1 Credit(s)™
- Nurses — maximum of 4 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Program Overview
Join our panel of experts for an interactive, live CME/CE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of multiple sclerosis (MS) in the rapidly evolving treatment landscape. This event features distinct tracks for specialists and primary care providers. Topics will include early recognition and differential diagnosis; the latest insights from clinical trials and real-world data on disease-modifying treatment options; recognition of disease progression, independent of relapse activity and its potential role in changing treatment sequences; and avenues to foster collaborative care and shared decision-making. Don't miss this unique opportunity to engage directly with leaders in the field and ensure your practice remains at the forefront of advancements in MS care.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
Multidisciplinary Joint Session
- Evaluate strategies that support prompt differential diagnosis of MS to ensure effective treatment initiation
- Describe current concepts of DMT management for relapsing MS, including different treatment strategies (immune reconstitution therapy and early aggressive vs escalation approaches)
- Assess the most recent efficacy and safety data on DMTs approved for relapsing and progressive forms of MS
- Discuss the clinical significance of emerging activity measures, such as PIRA, on MS treatment selection
- Explain how to effectively integrate shared decision-making and collaborative care into MS management plans
Specialist Track
- Identify imaging characteristics and other distinguishing clinical features that can used to differentiate MS from other demyelinating neurological disorders to guide appropriate treatment
- Select appropriate treatment, considering personalized benefit-to-risk profiles, and shared decision-making, for individual patients with MS or other demyelinating disorders
- Describe the mechanism of action and available data for investigational agents in MS
Primary Care Track
- Apply best practices in the symptomatic management in MS
- Implement strategies to provide whole-person care, beyond disease-specific management, for those living with MS
Faculty
Scott Newsome, DO, MSCS, FAAN, FANA
Course Director
Professor of Neurology
Johns Hopkins Hospital
Baltimore, MD
Kathleen Costello, MS, CRNP, MSCN
Interim CEO, Consortium of Multiple Sclerosis Centers
DBaltimore, MD
Daniel M. Harrison, MD, FAAN
Professor of Neurology
University of Maryland
School of Medicine
Baltimore, MD